Terbogrel
![]() | |
| Names | |
|---|---|
| IUPAC name
(5E)-6-{3-[tert-butyl(cyano)carbamimidamido]phenyl}-6-pyridin-3-ylhex-5-enoic acid | |
| Identifiers | |
| 149979-74-8 | |
| ChEMBL | ChEMBL281398 |
| ChemSpider | 4952549 |
| Jmol interactive 3D | Image |
| KEGG | D06077 |
| PubChem | 6449876 |
| UNII | 5Z4KWQ5OGN |
| |
| |
| Properties | |
| C23H27N5O2 | |
| Molar mass | 405.49 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
Terbogrel blocks thromboxanes and is expected to be useful in treating the vasoconstricting and platelet aggregating action of this compound. Terbogrel is a thromboxane A2 receptor antagonist.
See also
References
| ||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Monday, July 06, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
